Profound Medical Corp. (TSE:PRN - Get Free Report)'s stock price rose 0.1% on Tuesday . The company traded as high as C$12.00 and last traded at C$11.71. Approximately 7,128 shares changed hands during trading, a decline of 0% from the average daily volume of 7,141 shares. The stock had previously closed at C$11.70.
Analyst Ratings Changes
Separately, Raymond James raised shares of Profound Medical to a "strong-buy" rating in a research note on Saturday, November 9th.
Get Our Latest Report on Profound Medical
Profound Medical Price Performance
The company has a quick ratio of 14.98, a current ratio of 8.61 and a debt-to-equity ratio of 16.95. The stock has a market capitalization of C$282.74 million, a PE ratio of -6.96 and a beta of 0.81. The stock's 50-day moving average is C$10.78 and its 200 day moving average is C$11.61.
About Profound Medical
(
Get Free Report)
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum.
Featured Stories
Before you consider Profound Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Profound Medical wasn't on the list.
While Profound Medical currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
